{
  "ticker": "CRL",
  "last_updated": "2025-04-15T12:45:33.214155",
  "retention_years": 3,
  "count": 60,
  "transactions": [
    {
      "id": 24152,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 24132,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 24141,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 24147,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 24136,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 24128,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 9552,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 24138,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 24143,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 731,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 9549,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 24134,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 726,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 733,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 738,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 739,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 743,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 9544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 9551,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 9557,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 9558,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 9562,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 24127,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 24137,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 24145,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 24146,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 24151,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 728,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 729,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 730,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 734,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 735,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 736,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 737,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 740,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 742,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 9546,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 9547,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 9548,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 9553,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 9554,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 9555,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 9556,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 9559,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 9561,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 24130,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 24131,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 24133,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 24139,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 24140,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 24142,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 24144,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 24148,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 24150,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 741,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 9560,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 24149,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 732,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 9550,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 24135,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    }
  ]
}